|Buprenorphine||Reportable Limit: 1 ng/mL|
|Norbuprenorphine||Reportable Limit: 5 ng/mL|
|Naloxone||Reportable Limit: 5 ng/mL|
|Naltrexone||Reportable Limit: 5 ng/mL|
New and Emerging Drugs of Abuse, both illicit drugs and prescription medications, continuously enter the market causing demand for larger test panels to ensure patient recovery compliance. Synthetic Cannabinoids are a much more common drug of abuse today, in part caused by the ease of access to these illicit drugs. It is important to test for all potential drugs of abuse ensuring a patient’s safety and compliance during the critical early stages of recovery. LabSource recognizes and meets physicians' needs for current and highly accurate comprehensive toxicology testing results, along with meeting the need for rapid turn-around times for Addiction Medicine, Medication Assisted Therapy, and Intensive Outpatient Programs.
LabSource continually monitors the pulse of drug abuse trends to keep pace with the emerging drugs of abuse market. Synthetic designer drugs, like synthetic cannabinoids, cathinones, and phenethylamines, have grown in popularity based on the addictive properties and ease of access to these drugs. Testing for these drugs of abuse can ensure addiction recovery patients are remaining compliant with their treatment.
Extensive Drugs of Abuse Testing
Urine Drug Testing is an integral part of addiction medicine recovery by providing definitive evidence of patient compliance while removing the doubts of potential diversion. Definitive drug testing gives providers the resources to make patients accountable and can help enforce program compliance which supports better patient outcomes. Confirmatory testing using LC-MS/MS technology provides definitive patient testing results that are not found using Immunoassay Analyzer testing or Point-of-Care cups.
Meeting the Needs of Addiction Recovery Physicians with High Sensitivity Definitive Testing:
Benefits of Comprehensive Urine Drug Testing for Medication Monitoring / Risk Assessment
Improved Quality Care
Societal reasons: decrease drug diversion
*Internal LabSource testing data using High Sensitivity Definitive Testing Methodology
30 Day Account Integration – LabSource Quickly Communicates Issues That Can Affect Testing and Turn-Around Time.
Solid Phase Extraction & Concentrate Eliminates Interferences and Extracts Drugs to Increase Sensitivity. Evaporates Liquid Leaving High Concentrations of Drugs for Maximum Sensitivity.
Patient Results are Compared to the Patient’s Previous Results.
Automatic Re-test and Verification of Unexpected Results; We Re-test 10% of Specimens.
Ask About Our Clinical Toxicology Testing Services